论文部分内容阅读
目的:研究肺炎合并心衰的临床治疗方法及其疗效观察。方法:以本院2015年接收治疗的60例肺炎合并心衰患者为对象,按照治疗方法的不同进行组别划分,将接受常规治疗的30例患者分配到对照组,在此基础上,将接受西地兰治疗的30例患者分配到实验组,观察对比两组肺炎合并心衰患者的临床疗效。结果:实验组肺炎合并心衰患者的临床疗效要显著优于对照组(P<0.05)。患者治疗后的心率、心肌酶以及呼吸频率等方面情况优于对照组(P<0.05)。结论:在常规治疗的基础上,再对肺炎合并心衰患者采用西地兰治疗,其疗效显著,值得推广。
Objective: To study the clinical treatment of pneumonia complicated with heart failure and its curative effect. Methods: A total of 60 patients with pneumonia complicated with heart failure receiving treatment in our hospital in 2015 were divided into groups according to the different treatment methods, and 30 patients receiving routine treatment were assigned to the control group. On this basis, 30 patients treated with cedilamine were assigned to the experimental group, and the clinical efficacy of the two groups of patients with pneumonia complicated with heart failure was observed and compared. Results: The clinical efficacy of experimental pneumonia patients with heart failure was significantly better than that of the control group (P <0.05). The heart rate, myocardial enzyme and respiratory rate of patients after treatment were better than those of the control group (P <0.05). Conclusion: On the basis of routine treatment, cedilanid treatment in patients with pneumonia complicated with heart failure is significant and worthy of promotion.